The earlier GAPS book gives aminoglycosides and macrolides one gut-flora profile and antifungal drugs another. The first profile concerns physiological E. coli and Enterococci; the second concerns stimulation of Proteus-family bacteria and lactose-negative E. coli.[1]
Aminoglycosides and Macrolides, Grouped Together
In this passage, GAPS groups gentamicin and kanamycin as aminoglycosides and erythromycin as a macrolide, then discusses these examples with other named “-mycin” drugs. The suffix alone is not a universal pharmacological classification.[1]
A Specific Target: Physiological E. Coli and Enterococci
GAPS is precise about what this class damages: these drugs have a particularly devastating effect on colonies of beneficial gut bacteria, specifically physiological E. coli and Enterococci.[1] The word “physiological” matters here. It distinguishes the beneficial, resident strains of E. coli that belong in a healthy gut from the pathogenic strains that don’t. This antibiotic class goes after the beneficial version.
What a Prolonged Course Can Do
The source says a prolonged course can eliminate physiological E. coli and Enterococci from the digestive system, leaving it vulnerable to pathogenic E. coli and other microbes.[1]
Antifungal Antibiotics: A Different Class, a Different Effect
The English book discusses nystatin and amphotericin separately as antifungal antibiotics. It describes selective growth of Proteus-family bacteria and lactose-negative E. coli. The expanded German edition uses Proteobacteria in the corresponding passage.[1][2]
That is a different description from the loss of physiological E. coli and Enterococci in the preceding section. The two accounts should not be folded into one effect.
How the Two Bacterial Patterns Differ
The useful comparison is between loss of particular resident bacteria and growth of other bacteria. The book describes the first pattern for its aminoglycoside/macrolide examples and the second for the named antifungals.[1][2]
The class comparison puts those descriptions beside penicillins and tetracyclines. The penicillin article develops that group’s account; the separate tetracycline guide is still being prepared.
Frequently Asked Questions
What Makes Aminoglycosides and Macrolides Different from Penicillins?
GAPS attributes a specific, targeted effect to aminoglycosides and macrolides: devastation of physiological E. coli and Enterococci colonies, with a prolonged course capable of eliminating them entirely.[1] Penicillins, by contrast, are described as damaging Lactobacilli and Bifidobacteria while promoting different pathogenic organisms.
Do Antifungal Antibiotics Damage Gut Flora the Same Way Regular Antibiotics Do?
No. GAPS describes antifungal antibiotics as leading to selective stimulation of the Proteus family and lactose-negative E. coli, a growth-promotion effect rather than the bacterial elimination pattern seen with aminoglycosides and macrolides.[1]
Can Gut Flora Recover After Aminoglycosides or Macrolides Wipe Out Beneficial E. Coli?
This passage describes the damage pattern without assigning a recovery timeline. Use the gut-flora recovery timeline for the source’s organism-specific recovery windows.
How Does GAPS Distinguish Acute and Chronic Antimicrobial Use?
In Gut and Physiology Syndrome, Campbell-McBride says antibiotics can be lifesaving in acute infections. She distinguishes that use from prolonged treatment of chronic infections, where her emphasis is rebuilding the body and rebalancing its microbial community.[3]
Your Next Step
If the question is how long a named bacterial group takes to recover, read the recovery timeline. This class passage does not assign its own course-specific recovery date.[1][2]
If you want one place to keep food changes and observations together, my 90-Day Family Food Diary is part of the WFLI shop catalog.
References
- Campbell-McBride, N. Gut and Psychology Syndrome, supplied English edition (2004), Chapter 4, “What Can Damage Gut Flora?”, “Antibiotics,” PDF pages 37–39.
- Campbell-McBride, N. Gut and Psychology Syndrome, expanded second German edition (2015), Part One, Chapter 4, “Wodurch kann die Darmflora geschädigt werden?”, “Antibiotika.”
- Campbell-McBride, N. Gut and Physiology Syndrome (2020), A–Z, “Lyme disease, MSIDS (Multiple Systemic Infectious Diseases Syndrome) and other chronic infections.”
Leave a comment